1991
DOI: 10.1021/jm00111a001
|View full text |Cite
|
Sign up to set email alerts
|

Design of enzyme inhibitors using iterative protein crystallographic analysis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
77
0
4

Year Published

1995
1995
2008
2008

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 226 publications
(81 citation statements)
references
References 3 publications
0
77
0
4
Order By: Relevance
“…There has been increasing interest in recent years in the possibility of using the wealth of structural information available about proteins in order to design suitable inhibitors which could act as specific targetted drugs or at least as potential lead compounds in the search for specific drugs; this field has been termed structure assisted (or rational) drug design [125]. Some notable successes have been achieved in this area, for example:-(a) the design of inhibitors of angiotensin-converting enzyme; these inhibitors are used extensively as anti-hypertensive agents, and (b) inhibitors of the HIV type 1 protease which has been shown to be essential for virion assembly and maturation and is therefore considered an excellent target for inhibitory drug design [126,127].…”
Section: Ligand Binding and Drug Designmentioning
confidence: 99%
“…There has been increasing interest in recent years in the possibility of using the wealth of structural information available about proteins in order to design suitable inhibitors which could act as specific targetted drugs or at least as potential lead compounds in the search for specific drugs; this field has been termed structure assisted (or rational) drug design [125]. Some notable successes have been achieved in this area, for example:-(a) the design of inhibitors of angiotensin-converting enzyme; these inhibitors are used extensively as anti-hypertensive agents, and (b) inhibitors of the HIV type 1 protease which has been shown to be essential for virion assembly and maturation and is therefore considered an excellent target for inhibitory drug design [126,127].…”
Section: Ligand Binding and Drug Designmentioning
confidence: 99%
“…As a result, a number of (10)(11)(12)(13)(14)(15)(16). To further validate the in vivo significance of some of the highly significant markers that may be associated with chemoresponse to 5-FU-based therapy, a group of colorectal cancer patient specimens were selected.…”
Section: Introductionmentioning
confidence: 99%
“…This is due in part to the lack of a complete structural description of IN, which is crucial for understanding its enzymatic activity. Such knowledge is the foundation of rational drug design (6).…”
mentioning
confidence: 99%